CATALYST FINANCIAL PARTNERS LLC

Position in BSX — Boston Scientific Corp

CIK 1927537 BOSTON, MA

Position in BSX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$373,876

-$161,883 QoQ

Shares Held

8,760

+2.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#944

of 1,468 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $9,789,819 across 6 Medical Devices names. BSX ranks #5 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UFPT	Ufp Technologies Inc	26,457	$7,014,544
2	ABT	Abbott Laboratories	10,696	$970,555
3	SYK	Stryker Corp	1,904	$599,455
4	MDT	Medtronic plc	6,711	$525,001
5	BSX	Boston Scientific Corp This page	8,760	$373,876
6	EW	Edwards Lifesciences Corp	3,387	$306,388

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$373,876	8,760	+2.6%	Shares	Sole	2026-07-30
2026-03-31	$535,759	8,538	-9.9%	Shares	Sole	2026-05-12
2025-12-31	$903,727	9,478	+16.0%	Shares	Sole	2026-02-04
2025-09-30	$797,929	8,173	+2.3%	Shares	Sole	2025-11-12
2025-06-30	$858,313	7,991	-1.0%	Shares	Sole	2025-08-14
2025-03-31	$814,000	8,069	+13.2%	Shares	Sole	2025-05-02
2024-12-31	$636,583	7,127	+2.2%	Shares	Sole	2025-01-30
2024-09-30	$584,337	6,973	-0.9%	Shares	Sole	2024-10-28
2024-06-30	$541,765	7,035	+11.7%	Shares	Sole	2024-07-25
2024-03-31	$431,281	6,297	+12.2%	Shares	Sole	2024-04-23
2023-12-31	$324,545	5,614	+5.1%	Shares	Sole	2024-02-07
2023-09-30	$282,163	5,344	+6.1%	Shares	Sole	2023-10-26
2023-06-30	$272,451	5,037	+1.1%	Shares	Sole	2023-08-02
2023-03-31	$249,149	4,980	-1.6%	Shares	Sole	2023-04-11
2022-12-31	$234,126	5,060	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.